Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

HIV-1 e HIV-1 81

- Keyword

Abstract -

Keyword

Abstract
vertical transmission of
ro/Placenta infection in
e response in pregnant
o-child transmission of
erinatal transmission of
etric factors for vertical
vertical transmission of
to-child transmission of
sion?/Does a particular
rophylactic zidovudine/
in preventing perinatal
hildren at high risk for
on of Pol mutant T215Y
Vertical transmission of
o-child transmission of
isease among lactating
d/Zidovudine reduces, Brazil/Surveillance of
erinatal transmission of
ulatory setting with high
une, India/Shedding of
udy among relatives of
ganda/Risk factors for
-1 subtypes in Uganda/
udy among relatives of
Uganda/Prevalence of
pe E infected Thai men/
an women/Changes in
ntiretroviral therapy and
y than subtype B-Thai/
en plasma and seminal
e role in transmission of
ct/Active production of
on cervical shedding of
eral blood/Detection of
d clinical features in 125
osexual transmission of
defense forces/Risk for
Increasingly divergent
ecision-making among
ant Kenyan prostitutes/
ablished infection with
e antibody response in
n humoral responses to
zing antibodies against
aracterization of potent
vors of HIV-1 infection/
s infected with different
ation of salivary derived
d to multiple regions of
ponses early following
mmunologic correlates/
olonged suppression of
TL escape mutations in
S-mediated inhibition of
workers/New HLA-A11
toxic T cell response to
ism and mother to child
T lymphocytes (CTL) in
cyte reconstitution and
-term non-progressing
rug-induced variants in
dan adults/Cross-clade
pecific T cells/Effect of
oss-react with different
ivated gpl20-depleted
cytotoxicity (ADCC) in
kines, IL-12 and IL4, on
with macrophage tropic
II (CTL) activity against
dividuals infected with
D4+ T-cell production in
s expression of CD28 in
xpression in paediatric
Ilular immunity in acute

ens in T lymphocytes of
V Ethiopians: Effects of
antibodies to HHV-8 in
n children with perinatal
espiratory conditions in:A meta-analysis from fifteen prospe 23275 al mycobacteria (AM) in
transmission in utero/Placenta infec 23277 s regulatory regions by
infected women and risk of perinatal 23279 seminal fluid plasma of
in Abidjan, C6te d'lvoire/Study drug 31*/23280 helial neoplasia (CIN) in
and HIV-2 in the Gambia/A commun 23284 nd is a viral reservoir in
transmission in Malawi and Brazil/C 23285 ameters correlate with
below 3% in the German perinatal co 23291 nd malondialdehyde in:Effect of preventive measures in full 23301 IV infected patients/
subtype strain favor vertical transmis 23302 mmatory cytokines and
vertical transmission in the time of pr 23303 als/Cerebrospinal fluid
infection in newborns delivered withi 23305 topes on the V3 loop of
infection from S.o Paulo, Brazil/No 23307 1 infection/Antigen p24
isolates related to a high viral load un 23308 ear period/Meningitis in
in the north of Portugal/Vertical trans 23316 SCS) in asymptomatic
group O infection in Yaounde, Came 23318 assess the association/
infected women/Nipple disease am 23319 rent aphthous ulcers in
perinatal transmission even if only th 23326 ndividuals with primary
accidental contamination among he 23337 reated and drug-naive:Associations with bacterial vaginosi 527*/23347 ease inhibitor resistant
seroprevalence/Pelvic inflammatory 23348 utations on different
DNA subtypes C and A in genital ulc 23353 n T215Y/F in the same
persistently seronegative prostitutes 23354 ce related mutations in
infection in a rural population of 15,0 23356 nt regarding the use of
heterosexual transmission: relations 23357 tion of mutations in the
persistently seronegative prostitutes 23362 with acute and chronic
and syphilis among women in Ugand 23383 combination therapy in
viral load in blood and semen of subt 23390 r diagnosis of pediatric
viral load after discontinuation of oral 23391 eful in reducing vertical
shedding from anorectal mucosa/An 23393 vaginal flora, and risk of
subtype RNA levels in semen of HIV- 23395 ulticenter evaluation of
viral load in antiretroviral-naive Brazil 23399 tection of antibodies to
in advanced HIV disease and advan 23401 wi/Sero-prevalence of
in the female genital tract/Active pro 23442 Community cohorts for
DNA/Effect of intrauterine device us 23453 binant BCG vaccine for
in the female genital tract: Associatio 23488 litated DNA vaccine for
infected women/Epidemiological an 23496 ermination of prevalent
infection among women in Honduras 23506 cebo controlled phase I
seroconversion in the Ugandan peop 519*/23507 ses with a combination
seroprevalence in male and female c 23560 ant for vaccination with
infected women/Determinants of co 24197 el of sexual behavior of
specific mucosal IgA in a cohort of HI 329*/31101 ns of secretory IgA with
primary isolates in the hu-PBL-SCID 330*/31103 peptide for detection of
infection is directed against viral deb 331*/31104 tection of antibodies to
envelope early in infection and subs 31107 V-1/O and HIV-2/Murex
primary isolates positively correlate 31109 aphic test/Detection of
sera able to neutralize 17 primary HI 31113 he Shiloov tube/In vitro
specific immune responses and CC- 31114 Performance of calypte
strains/Humoral immune response i 31117 zer/Performance of an
specific IgA antibodies/Characteriza 31119 n criteria/Sensitivity of
subtype E/HIV-specific cytotoxic T ly 599*/31120 r serologic diagnosis of
clade-B infection/Cross-clade envel 601*/31122 /Field evaluation of the
specific cytotoxic T-lymphocyte resp 600*/31123 evaluation of Amplicor
viremia results in profound but incom 112*/31124 r sensitive detection of
infection/Rare occurrence of CTL es 31125 nge and performance of
infection of macrophages: p38 MAP 31126 asurement by Amplicor
subtype E cytotoxic T lymphocyte (C 603*/31127 e assay/Quantitation of
proteins among HLA disparate North 602*/31128 apy including indinavir/
transmission in Kenya/Class I MHC 210*/31131 mutations/Genotyping
infected children: CTL recognition of 604*/31132 ersions of the Amplicor
specific T cell responses during highl 113*/31134 nge of Roche Amplicor
infected individual/Recognition of tw 31135 rison of proviral DNA in
reverse transcriptase/Cytotoxic T ly 31137 CR) for the detection of
specific cytotoxic T lymphocyte (CTL 31139 plasma RNA for non-B
infection on chemokine receptor exp 31141 say for the detection of
gag subtypes/Cytotoxic T lymphocyt 31149 nt in situ hybridization to
immunogen (REMUNETM) in HIV-1 s 31151 Discrimination between
infected patients receiving a recombi 31152 ssay of T- and M-tropic
specific CTL activity/Effect of the Th 31153 combination-therapy of
BaL/Peripheral blood mononuclear c 31154 deficiency virus type 1 (
proteins is not associated with risk of 31155 ed glucose tolerance in
and Mycobacterium tuberculosis is a 31167 ranscriptase inhibitor of
infection/Telomere length and telom 271*/31168 f triple combination in
infected children: Correlation with pr 31173 /Destruction of gp41 of
infection predicts disease progressio 31176 esponse to treatment of
infection following antiretroviral thera 115*/31177 st treatment course for

(+) individuals/Coexpression of CD6 31181 and characterization of
infection/lmmunohaematological ref 31183 nd zidovudine-resistant
positive individuals and normal blood 31192 e analogue/Inhibition of
infection/Primary infection of human 31201 ations in therapy-naive
seropositive adults in Kenya/Clinical 31208 henotypic detection of

+ patients/Infection by atypical myco 31210
Tat: Transactivation mechanisms of 31223
infected individuals/High detection r 32101
+ women/Immunological parameters 32134
patients/The benign cystic lymphoe 32137
plasma viral load and are improved b 32139
infected individuals and patients with 32187
RNA, as measured by the Gen-Prob 32195
associated neurodegeneration: Onc 32200
RNA levels and efavirenz concentrat 32202
gp120 and neuronal cells/Shared an 32217
in cerebrospinal fluid in patients with 32222
infected patients: Results from a sev 32224
infection in Mulago hospital/Materna 32229
infection and miscarriage: A retrospe 32231
(+) and HIV-1(-) patients/Expressio 32250
infection/Frequency of transmission 228*/32280
infected patients as predictor of treat 233*/32282
to a recently infected antiretroviral-n 32288
quasi-species/Patients harbouring b 32296
reverse transcriptase is compatible 32300
pol gene of patients treated with a co 32302
genotyping for a community consorti 32307
reverse transcriptase (RT) gene and 32311
infection/Adherence to quadruple th 32328
positive gay men/Attitudes and age 32331
infection and quantification of virus lo 32442
transmission?/ls incomplete 076 AC 32450
infection and STDs/Vaginal coloniza 33148
RNA levels in dried plasma and whol 33166
group 0 by eight screening and four 33200
and other blood borne diseases amo 33206
vaccine trials in northern Thailand; th 33212
protects cynomolgus monkeys from 33213
prevention/AVEG 031: Phase I eval 33216
subtypes in South Africa and the con 33218
vaccine trial in Uganda/Recruitment 33219
vaccine regimen/CTL and neutralizi 33221
derived multi-epitope polypeptides ( 33224
seropositive Brazilian women/A beli 33320
gp120: Potential pitfalls of anti-HIV E 162*/41101
group M and group 0 infections in ra 41104
/Evaluation of a locally produced part 41105.2.0 is a highly sensitive and specific 41106
subtypes by a new rapid immunochr 41107
antibody induction: Testing of the Shi 41112
urine EIA in three US populations/P 41114, HIV-2 and HIV-1 group 0 immunoas 41115
group M Western Blot for the confirm 41122
and 2/Evaluation of a fast method (H 41125
Amplicor Monitor and NucliSens qua 41127
Monitor with added primer set with q 41128
RNA of diverse origins, including typ 343*/41129
subtypes of the COBASAMPLICOR 41130
Monitor: Analysis of within-lot and be 41134
virus load by a TaqMan "-based prod 41137
proviral DNA and plasma RNA chan 41140
reverse transcriptase to detect AZT-r 41143
monitor test with new gag primers, a 41145
Monitor assay using ultra sensitive s 41146
and HIV-2 infected babies in relation 41147
DNA/A high input PCR method (Meg 41150
subtypes using the HIV-1 MonitorTM w 41154
DNA in blood samples from Tanzani 41155
using PCR-generated, single-strand 41159
and HIV-2 by PCR of serologically do 41160, and its application to clinical isolatio 41163
infection/Plasma concentrations of I 41164
) subtype on HIV antibody detection i 41173
infected patients treated with proteas 179*/41177
/S-1153, a new nonnucleoside rever 553*/41181
experienced patients/The effect of tr 41189
envelope by its catalytic antibody/D 41190
infected children with the protease in 41191
infected treatment-naive patients/Th 41194

resistant to modified cyclodextrin sulf 41198
isolates in vitro/Two- and three-prot 41201
replication by newly developed poly 41205
positive German seroconvertors irre 41208
resistance to lamivudine (3TC) and n 41209